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Abstract
Background
Chronic rhinosinusitis (CRS) is characterized by epithelial activation and chronic T-cell infil-
tration in sinonasal mucosa and nasal polyps. IL-33 is a new cytokine of the IL-1 cytokine
family that has a pro-inflammatory and Th2 type cytokine induction property. The role of IL-
33 in the pathomechanisms of CRS and its interaction with other T cell subsets remain to be
fully understood.
Methods
The main trigger for IL-33 mRNA expression in primary human sinonasal epithelial cells
was determined in multiple cytokine and T-cell stimulated cultures. The effects of IL-33 on
naïve, Th0 and memory T-cells was studied by PCR, ELISA and flow cytometry. Biopsies
from sinus tissue were analyzed by PCR and immunofluorescence for the presence of dif-
ferent cytokines and receptors with a special focus on IL-33.
Results
IL-33 was mainly induced by IFN-γ in primary sinonasal epithelial cells, and induced a typi-
cal CRSwNP Th2 favoring cytokine profile upon co-culture with T-helper cell subsets. IL-33
and its receptor ST2 were highly expressed in the inflamed epithelial tissue of CRS patients.
While IL-33 was significantly up-regulated in the epithelium for CRSsNP, its receptor was
higher expressed in sinus tissue from CRSwNP.
Conclusions
The present study delineates the influence of IL-33 in upper airway epithelium and a poten-
tial role of IL-33 in chronic inflammation of CRSwNP by enhancing Th2 type cytokine
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Introduction
Chronic rhinosinusitis (CRS) is defined as an inflammation of the nose and the paranasal si-
nuses and is estimated to affect more than 200 million patients worldwide [1]. The inflammato-
ry response represents an essential mechanism of defense of the mucosa against viral, fungal
and bacterial infections [2–4]. All of them lead to an overwhelming inflammatory response re-
sulting in tissue damage, healing and remodeling [5–7]. However, the key players in this pro-
cess remain to be defined in detail[8]. Based on current knowledge on CRS, several T-cell
subsets are involved in the chronic phase that succeeds over counter-regulatory and anti-in-
flammatory mechanisms controlling these subsets [9].
Th2 cytokines and T-regulatory (Treg) cell-associated transcription factors (FOXP3) and
cytokines (IL-10, TGF-β) have been shown to be altered in sinus tissue from CRS patients [10–
12]. The recently described alarmin, IL-33 is an interesting target, since it is considered to act
as an endogenous danger signal that is upregulated upon tissue damage or inflammation
[13,14]. IL-33 is considered to be among the most potent inducers of Th2 type inflammation
on mucosal tissues and signals via its receptor ST2. [15] It has been reported to induce IL-13
and IL-5 and thereby may counteract Th1 and also Th17 inflammatory responses. IL-33 has re-
cently come into focus of research in CRS, as its receptor ST2 has been shown to be elevated in
CRSwNP and IL-33 responsive innate lymphoid cells were found in nasal polyps [16,17]. Fur-
thermore, constitutive IL-33 expression is present in epithelial cell cultures of recalcitrant
CRSwNP patients [18]. These facts point to the idea of IL-33 as a contributor to the pathogene-
sis of CRS with its link to a Th2 predominant inflammation as it does in allergic disease[19].
The present study focused on the IL-33 mediated induction via T-cell and T-cell-related cy-
tokines and the interrelationship between IL-33 and T-helper subsets. We demonstrate that IL-
33 expressing cells are present in CRS tissues and identified IFN-γ as a potent IL-33 inducing
factor. In addition, IL-33 skews inflammation towards a Th2 predominance and thus may con-
tribute to the pathogenesis and chronic nature of CRS.
Methods
Subjects
Seventy patients referred to sinus surgery with clinical and radiologic evidence for chronic rhi-
nosinusitis, according to the definition in the European Position Paper on Rhinosinusitis and
Nasal Polyps,[20] were included in the study. The control group consisted of 19 patients oper-
ated on the paranasal sinuses for reasons unrelated to CRS. Patients with immune deficiency or
under systemic immunosuppressive therapy were excluded. Both systemic and local corticoste-
roid treatment was stopped 6 weeks prior to biopsies. All operations were performed in exacer-
bation free intervals. Patient history related to allergy was recorded and allergy testing was
performed by measurement of the total serum IgE level and the ImmunoCAP (Thermo Fisher,
Reinach, Switzerland) SX1 test for a panel of allergens (for further details please refer to the on-
line supplementary).
Tissue samples were obtained during endoscopic, endonasal approaches under general an-
aesthesia. In detail, the chosen procedure was adapted to the underlying disease and has been
carried out in a standardized manner [21]. Sinonasal biopsies were collected in the region of
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affected mucosa in the anterior ethmoid, in particular the ethmoid bulla or uncinate process.
In CRSwNP patients, samples were taken directly from polypoid tissue in the region of the in-
fundibulum ethmoidale. In control patients, who did not need paranasal sinus surgery either
the lateral portion of the middle turbinate or mucosa from the middle meatus was harvested,
always as far away as possible from the potential pathology.
In parallel, peripheral blood was taken into lithium heparine tubes by venopuncture. Writ-
ten informed consents were obtained from all patients. The study protocols, including patient
information forms, have been approved by the ethical committee of the canton of Zurich
(#528).
Real time PCR
Sinus biopsies were stored in RNA-later (Quiagen, Hilden, Germany) immediately after re-
moval, and total RNA was isolated from the homogenate within 24 h after homogenization
with RNase-free beads using a Precellys 24 (Bertin Technologies, Montigny-le-Bretonneux,
France). 6.5 ng cDNA or standardized cell numbers were applied for real time RT-PCR. The
details and primer sequences are found in the online repository.
Immunofluorescence
Biopsies were immediately embedded in Optimal Cutting Temperature (OCT) compound
(Sacura Seiki, Tokyo, Japan) and stored at -80°. Samples were cut (7 μm), mounted, air-dried
and fixed in 4% paraformaldehyde (PFA), permeabilized and blocked.
IL-33 staining was performed with a primary antibody against IL-33 (1:100; clone Nessy-1
ALEXIS Biochemicals, San Diego, CA, USA) and a secondary Alexa Fluor1 488 labeled goat
anti mouse antibody (1:4000 Biolegend, San Diego, CA, US). Slides were mounted with Vecta-
shield Mounting Medium containing 4‘, 6-diamino-2-phenylindole (DAPI) for nuclear stain-
ing (Vector Labolatories, Burlingame, CA, USA) and examined by confocal laser scanning
microscope Leica TCS SP5 (Leica Microsystems, Glattbrugg, Switzerland).
ELISA, flowctometry andWetern blot
Multiplex-ELISA (Bioplex, Bio-Rad Laboratories, Hercules, CA, USA) was performed accord-
ing to the manufacturers´ instructions. IL-33 ELISA was performed using the human IL-33
ELISA development kit 900-K398 (PeproTech, Rocky Hill, NJ, USA) according to the
manufacturer’s instructions.
The number of INF-γ-, IL-13-, IL-4- and IL17A-producing CD3pos CD4pos cells was as-
sessed in naïve and memory subsets. Intracellular and surface staining of T-cells as well as pro-
cedures are described elsewhere [22–25].
Western blots were performed as described previously using the same primary antibody
against IL-33 as described above (clone Nessy-1 ALEXIS Biochemicals, San Diego, CA, USA)
[26].
Isolation and culture of primary HSEC
Primary HSEC were isolated and purity was checked as described [9] and subjected to different
stimuli at 80% confluence. Cells between passages 1 and 3 were used in all experiments. HSEC
cells for functional experiments were cultured in serum-free bronchial epithelial cell medium
in humidified atmosphere containing 5% CO2 at 37°C and grown until 80% confluence and
subjected to cytokines (for details we refer to the online repository). Messenger RNA induction
was monitored after 8h and protein induction was measured in cell free supernatant after 72h.
IL-33 Induction in Chronic Rhinosinusitis
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Depending on the respective experiment cells were cultured in 48 or 6 well plates flat bottom
plates.
The cytokines and its concentrations used throughout the study are found in the online
repository.
T-cell experiments
Naive CD4+ T-cells (CD45 RA+) and CD4+ CD45 RO+ T-cells were purified from peripheral
blood mononuclear cells (PBMC) from buffy coats via magnetic cell sorting [27,28]. In brief,
initially CD4+ RA+ cells were isolated via negative selection (naïve T-cell isolation kit, Miltenyi
Biotech Bergisch Gladbach, Germany). Thereafter residual CD45RA+RO+ double positive
cells were removed by an additional CD45RO depletion step.
Direct impact of IL-33 on CD3+CD4+CD45RA+ cytokine polarization was monitored. To
asses direct impact of IL-33 on naïve T-cells in the absence of initial TCR stimulation, naïve T-
cells were stimulated for 7 days with IL-33 (10ng/ml) in the presence of IL-2 (100 IU/ml).
For T-cell differentiation, naïve T-cells were stimulated with a combination of soluble anti-
CD2 (0.25 μg/mL; CLB Amsterdam Netherlands), anti-CD3 (0.25 μg/mL, clone OKT3, ATCC,
Maryland, USA), and anti-CD28 (0.25 μg/mL clone 15E8, CLB Amsterdam Netherlands) in
the presence of IL-33 (10 ng/ml) and of different cytokine cocktails that drive differentiation
direction Th0, Th1, Th2, Th9, Th17 and Treg as described in detail by Burgler et al.[27] Polari-
zation was confirmed after TCR re-stimulated via PCR analysis.
Memory T-cells were isolated via positive isolation of the CD45RO-positive fraction CD3+
CD4+ (T-helper isolation kit II, Miltenyi Biotec, Bergisch Gladbach, Germany) subset. The
memory subset was co cultured with IL-33 (10 ng/ml) in the presence of IL-2 (100 IU/ml) for
7 days and cytokines were measured in cell free supernatant via bead-based ELISA.
Statistical analysis
Statistical comparison between the groups was performed by nonparametric Mann-Whitney
U-test, Wilcoxon Rank Sum test or unpaired Student‘s t-test according to statistical standards
based on the number of samples and homogeneity/heterogenity of the datasets. For frequency
analysis Fisher’s exact test was applied. A p-value< 0.05 was considered significant.
Results
IL-33 is up-regulated in primary human sinus epithelial cells upon IFN-γ
stimulation
In order to investigate the most potent inducers of IL-33 in human primary sinonasal epithelial
cells, a large panel of cytokines and combinations of such were used to stimulate epithelial cell
cultures. The Th1 prototype cytokine IFN-γ turned out to be the most effective inducer of IL-
33 mRNA (Fig 1A). This IFN-γ -related effect was found unrelated to the clinical features of
the donor (Fig 1B). Both IL-33 mRNA and IL-33 protein expression were increased by IFN-γ
in a dose dependent manner (Fig 1C). The biologically active, non-cleaved version of IL-33,
was confirmed by Western Blot (Fig 1D). Thereafter, we confirmed the Th1 dependence of our
findings by adding different T-cells subsets, differentiated from naïve T-cells, to the epithelial
cells. Only Th1 cells significantly upregulated IL-33 mRNA expression in primary human sino-
nasal epithelial cell cultures (Fig 1E). Th2, Th17, Th9 and Treg cells did not exert any influence
on IL-33 expression.
IL-33 Induction in Chronic Rhinosinusitis
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Modulation of naïve, memory and Th0 responses by IL-33
Potential interactions between IL-33 and Th-cell subsets were investigated in naïve and effec-
tor/memory T-cells. First, we investigated the impact of IL-33 on purified naïve T-cells. A Th2
favoring effect of naïve T-cells in the presence of IL-2 was observed at mRNA levels without
significantly affecting IFN-γ and IL-17 mRNA production (Fig 2A). IL-33 seems to be more ef-
fective on memory and effector T-cell subsets, which actually play the key role in tissue inflam-
mation. Consequently, CD45RO+ CD4+ T-cells were isolated from healthy donors and
cultured with IL-33, which led to a significant up-regulation of the Th2 type cytokines IL-4 and
IL-5 (Fig 2B).
Thereafter, the impact of IL-33 during the course of T-cell maturation from naïve cells to-
wards Th0 was investigated. The frequency of IL-13-producing cells was up-regulated, whereas
IFN-γ-producing cells decreased in 4 out of five experiments. There was no evidence for the in-
duction of IL-17A under these conditions (Fig 3).
Sinus tissue from chronic rhinosinusitis patients shows a mixed pro-
inflammatory cytokine profile and an upregulation of IL-33
Whole sinus tissue mRNA analysis of a broad panel of cytokines, cytokine receptors and tran-
scription factors was performed to investigate the general proinflammatory cytokine profile
and also in relationship with Th1, Th2, Th17 and Treg-cell-subsets. The inflammatory charac-
ter of CRSwNP is represented with significantly elevated IL-1β, IL-6, IL-8, IL-13 and ST2 com-
pared to controls samples (Fig 4). In line with previous publications CRSwNP represent a more
Th2 type inflammation as reflected in significantly augmented IL13 and ST2 expression and
and a trendwise increased IL5 expression. In CRSsNP IL-8, IL-33, and ST2 were significantly
elevated compared to controls. The upregulation of IL-33 in CRSsNP and of its receptor ST2 in
both types of CRS led to an investigation of protein expression in the tissue. An enhanced ex-
pression of IL-33 in CRS patients compared to control tissue was visualized in epithelial cells
by immuno-fluorescent staining (Fig 5).
Discussion
Chronic rhinosinusitis (CRS) is defined as a chronic inflammation of the nose and the parana-
sal sinuses. Both T-cells and epithelial cells contribute to this state. To date, counter regulatory
mechanisms of inflammation that are generated from the tissues as a result of the inflammato-
ry processes and in turn favor chronic inflammation have been poorly understood. Particularly,
in the context of rhinitis/rhinosinusitis and T-cell inflammation, there is scant data for a role of
IL-33. In the present study we demonstrate the interrelationship between the epithelium, the
influence of IL-33 and T-cells as important players in inflammation.
IL-33 possesses several functions that fit to the picture of CRS as a member of the IL-1 cyto-
kine family [29,30]. Polarized Th2 cells, mast cells and basophils produce enhanced amounts
of Th2 type cytokines in response to IL-33. Eosinophils are among the major responder cells
[31]. A potential role in nasal polyposis due to a linkage of IL-33 polymorphisms to clinical dis-
ease and on type2 innate lymphoid cells has been suggested [32]. In this study an enrichment
of IL-33 responsive CRTH2+ ILC2s is shown in nasal polyps providing a source of TH2
Fig 1. IFN-γ is a strong inducer of IL-33 in sinonasal epithelial cells. Primary sinus epithelial cells (CRS patient) were subjected to T-cell lineage specific
or T-cell related cytokines or their combinations. mRNA expression of IL-33 was measured via real time RT-PCR. IFN-γ induced a relevant increase in IL-33
(A). The observed effects are independent of the source of HSEC cells (B; n = 5; mRNA levels are expressed as fold expression of the unstimulated control).
The induction of IL-33 via IFNγwas dose dependent (C). The presence of the uncleaved form of IL-33 after co-culture of HSEC with 50 μg/ml IFNγ was
confirmed by western blot (D). Only Th1 cells, but not Th2, Th9, Th17 or Treg were significantly up-regulated IL-33 mRNA expression in HSECS (E).
doi:10.1371/journal.pone.0123163.g001
IL-33 Induction in Chronic Rhinosinusitis
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cytokines. Our findings were in line with previous reports, where ST2 expression was elevated
in CRSwNP/eosinophilic CRS [16,17]. The reports on the levels of IL-33 itself are heteroge-
neous. Elevated IL-33 levels were observed in recalcitrant CRS [18]. However, no information
about the site of inflammation has been provided in these studies and the inducers for IL-33 re-
mained to be elucidated. In our study, IL-33 was higher in CRSsNP, whereas its receptor ST2
was higher in the CRSwNP group. This may relate to types of inflammation described for
CRSsNP and CRSwNP with a higher frequency of ST2-bearing cells (i.e. Th2 cells and Th2-re-
lated cells). We suggest that the overexpression of ST2 in CRSwNP represents a more accurate
marker of chronic IL-33 driven inflammation. As IL-33 itself is only released upon epithelial
cell destruction as a potential counter-regulator of the initial Th1-caused injury it may result in
Fig 2. IL-33 favors Th2 cell development. Naïve T-cells were isolated from PBMCs of and purified via magnetic cell sorting. CD45RA+CD45RO- CD4+ T-
cells were stimulated with IL-33 in the presence of IL-2 for 5 days and thereafter subjected to TCR stimulation. mRNA expression was assessed after 8 hours
(A, n = 5). Th2-type cytokine production of purified memory T-cells (CD45RO+CD45RA- CD4+ T-cells) was significantly increased by IL-33. (B, n = 8) Mean
+/- SEM.
doi:10.1371/journal.pone.0123163.g002
IL-33 Induction in Chronic Rhinosinusitis
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a collateral Th2 inflammation as a result of the Th2 skewed local milieu with a high ST2 recep-
tor and Th2 density in CRSwNP.
It is still unclear what the main factors for the induction of IL33 at mucosal sides are. Here,
we provide the first data on induction of IL-33 and its high expression confirmed at a protein
level in human upper airway epithelium. We demonstrate in the present study an important
role for IFN-that is released e.g. via viral infections in the induction of epithelial cell-mediated
inflammation and, in a second step, the induction of apoptosis of sinus epithelial cells [9]. Re-
cently, an important role of IL-33 in anti-viral defense has been reported [33]. The linkage of
Fig 3. Impact of IL-33 on Th0 cell differentiation from naïve T cells. Naïve T-cells from buffy coats were differentiated into Th0 (n = 5) in the presence or
absence of IL-33 (10 ng/ml) and thereafter subjected to intracellular cytokine staining. IL-33 promoted an increase in Th2-producing cells in four out of five
experiments. There was no evidence of an IL-17 induction.
doi:10.1371/journal.pone.0123163.g003
IL-33 Induction in Chronic Rhinosinusitis
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viral infection IL33 and Th2 inflammation in the context of asthma has been fostered by a re-
cent publication that described the induction of IL33 in a human experimental model of rhino-
virus infection [34,35]. In line with our study, the induction of IL-33 by IFN-γhas been shown
in keratinocytes [36] and gastric epithelial cells [37]. In clinically stable cystic fibrosis, IL-33
has been correlated with IL-8 and IL-13 levels in broncho-alveolar lavage fluid.[38] Especially,
the importance of apoptosis in the termination of the pro-inflammatory feedback loop seems
to be an important anti-inflammatory mechanism [29]. This could be an additional so far un-
defined, mechanism to limit inflammation if necrosis occurs, whereas the process of apoptosis
Fig 4. Sinus tissue from chronic rhinosinusitis patients shows a mixed pro-inflammatory cytokine profile.Whole sinus tissue mRNA from CRS
patients (CRSsNP n = 16; CRSwNP n = 8) and controls (n = 8) of an array of cytokines and transcription factors was quantified by real time PCR (Mann
Whitney U-Test; mean +/- SEM).
doi:10.1371/journal.pone.0123163.g004
IL-33 Induction in Chronic Rhinosinusitis
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itself limits IL-33- mediated effects via cleavage and inactivation. In addition, the Th2 inducing
role of IL-33 may act as an important mediator in the skew to a Th2 microenvironment. In line
with our data, an association between the polymorphisms of the receptor for IL-33 and surgery
unresponsive CRS has been reported [39]. The loci rs13431828 of the interleukin-1 receptor-
like gene showed the highest association with CRS.
Nasal polyps are one of the major phenotypes in the context of CRS and differential cytokine
patterns and have been described [40]. Although general patterns like elevated Th2 type cytokines,
such as elevated IL-5 and IL-13 expression with concomitant ST2 up-regulation were detected in
CRSwNP, some differences as compared to recently published datasets were observed. We could
not detect GATA3 and Tbet up-regulation with FOXP3 down-regulation in CRSwNP as observed
by others [11,41]. This may reflect a more pronounced heterogeneity within our population. The
herein described patient group seems to represent a more inflammatory phenotype that is closer
to the so called “Chinese phenotype” in terms of IL-1β, IL-6 up-regulation and IL-17A linkage,
but also shows strong Th2 type phenomena as observed in other Caucasian populations [12,41].
Our findings provide important data for multi-faceted types of inflammation in CRS both
with or without NP. There is definitely a possibility that different endotypes and cytokine pro-
files in a farm and mountain dominated environment, such as Switzerland with different living
circumstances harbor the possibility to show different inflammatory patterns. There is a high
likelihood that there will be new endotypes of CRS that will be more and more defined as cur-
rently happening for asthma [5,42] and the mixed cytokine profiles demonstrated here will be
better explained and gain more attention.
In the present study, IL-33 induces Th2 type cytokines in naïve and memory T-cells. IL-33/
ST-2 driven induction of Th2 cytokine secreting cells from naïve T-cells was observed in an
IL-4 independent way [43,44]. Although we detected IFN-γin these conditions, we cannot
know whether the observed values reflect the level that is already suppressed by IL-33 or by
other IFN-γ-suppressing conditions such as Th2 cytokines. We consider local inflammation in
CRS tissue of dynamic nature and the co-occurrence of several T-cell types is a pre-requisite to
make chronicity of the disease possible.
In conclusion, the present study suggests novel mechanisms due to the mixed T cell cytokine
profile and their interaction with IL-33. IL-33 that is up-regulated by IFN-γcontributes to the
Th2 arm, which may enhance chronicity in CRSwNP. With the results from our single-cytokine
Fig 5. IL-33 expression in CRS tissue. IL-33 is expressed in the sinus epithelium of CRS patients in vivo (A; one out of three independent experiments;
CRSwNP shown). Nuclear staining with DAPI in blue, IL-33 in green.
doi:10.1371/journal.pone.0123163.g005
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experiments a tissue model is suggested, where IFN-γdriven tissue damage leads to the expres-
sion of IL-33 as an alarmin, which in turn favors the switch from a Th1/Th17 to a rather Th2
type inflammation (Fig 6).
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